Poll Answers

< back to all questions

Question of the day

Do you take a low-dose aspirin every day?

Yes

I take low-dose aspirin, but not every day

Other

N/A — I do not have a personal T1D connection

Please select an option

We received 221 answers

Trending News

Poll Answers

Question of the day

MOST COMMENTED

T1D Exchange Outcomes Research Team Presents In-Person at the 2024 ADA 84th Scientific Sessions

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

T1D Exchange Announces 21 Real-World Data Presentations at the American Diabetes Association (ADA) 84th Scientific Sessions

Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control

Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Successful Strategies to Reduce Delays in Quality Data Reporting

Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects

Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries

Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative

RECENT

T1D Exchange Outcomes Research Team Presents In-Person at the 2024 ADA 84th Scientific Sessions

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

T1D Exchange Announces 21 Real-World Data Presentations at the American Diabetes Association (ADA) 84th Scientific Sessions

Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control

Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Successful Strategies to Reduce Delays in Quality Data Reporting

Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects

Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries

Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative

Privacy Policy

Terms of Use

Follow Us

Account successfully created.

Your Account Type

Select Topics

We're preparing your personalized page.

Subscribe Now

Trending News

Poll Answers

Sign up for a new account.

Sign up by entering your info below.

Welcome back

Reset Your Password

Question of the day

MOST COMMENTED

T1D Exchange Outcomes Research Team Presents In-Person at the 2024 ADA 84th Scientific Sessions

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

T1D Exchange Announces 21 Real-World Data Presentations at the American Diabetes Association (ADA) 84th Scientific Sessions

Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control

Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Successful Strategies to Reduce Delays in Quality Data Reporting

Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects

Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries

Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative

RECENT

T1D Exchange Outcomes Research Team Presents In-Person at the 2024 ADA 84th Scientific Sessions

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

T1D Exchange Announces 21 Real-World Data Presentations at the American Diabetes Association (ADA) 84th Scientific Sessions

Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control

Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)

Successful Strategies to Reduce Delays in Quality Data Reporting

Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects

Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries

Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative

Privacy Policy

Terms of Use

Follow Us

Account successfully created.

Your Account Type

Select Topics

We're preparing your personalized page.